Brought to you by:
Study: Social support associated with better PAD health outcomes
Patients with peripheral arterial disease (PAD) reporting lower levels of social support experience worse health outcomes, a new Yale-led study finds. Social support is thought to bolster cardiovascular health by facilitating health-promoting behaviors and acting as a buffer against the…
New ESC guidelines combine peripheral arterial and aortic diseases for first time, emphasising interconnectivity of whole arterial system
The European Society of Cardiology (ESC) has today published its 2024 guidelines for the management of peripheral arterial and aortic diseases (PAAD), evaluating these vascular conditions together as part of the same cardiovascular system. The guidelines are aimed at cardiologists,…
First-in-human study of SonoThrombectomy system completed
SonoVascular has announced the successful initiation of its first-in-human study (FIH) of the company’s SonoThrombectomy system, an ultrasound-facilitated, thrombolytic-enhanced platform that utilizes multiple mechanisms of action to treat patients with venous thromboembolism (VTE). The catheter-based system combines microbubble-mediated cavitation with…
Inari Medical updates ClotTriever XL IFU amid FDA recall notice
The Food and Drug Administration (FDA) has issued a Class I recall—the most serious type—for Inari Medical‘s ClotTriever XL, 30mm device due to reports of patient injury, and death from device entrapment and pulmonary emboli (PE). The device remains on…
SCVS issues call for abstracts as deadline approaches for 2025 symposium
The Society for Clinical Vascular Surgery (SCVS) has issued a call for abstracts for its 2025 Annual Symposium, with just under two weeks left until the deadline. Once again, the SCVS will give special consideration to papers deemed “collaboration abstracts”—those…
Eastern Vascular Society set to stage day of service during 2024 annual meeting
The Eastern Vascular Society (EVS) has incorporated a day of service into its 2024 annual meeting, being held in Charleston, South Carolina (Sept. 19–22). Leading vascular surgeons, alongside nurse practitioners and advanced practice partners, will educate local residents about their…
SVS sets modest dues increase to drive enhanced member benefits
The Society for Vascular Surgery (SVS) announced an increase in membership dues for 2024 for Active members, a strategic move aimed at enhancing support and resources for its members. This adjustment will bolster professional development opportunities, networking, advocacy and resources…
‘Choosing the right devices for the right patients’: Surgeon-scientist secures NIH funding to develop MRI technique for precision PAD care
Michael Conte, MD, recently used his 2024 Veith Lecture to call on young vascular surgeons on the peripheral arterial disease (PAD) frontlines to drive the space forward amid a great unmet need. The professor and chief of vascular and endovascular…
Physician-modified endografts ‘safe and effective’ for thoracoabdominal and complex AAA repair
Researchers have reported a 94% technical success rate among other key findings from a recent international, multicentre, single-arm cohort study of physician-modified endografts (PMEGs) for thoracoabdominal and complex abdominal aortic aneurysm (AAA) repair. The work has been published in the…
SCOREPAD seeks to address ‘alarmingly high’ mortality in CLTI patients with underlying coronary disease
A new research letter underscores the need to improve long-term survival following lower extremity revascularization for chronic limb-threatening ischemia (CLTI), setting out a randomized controlled trial to examine the impact of coronary artery ischemia testing in these patients. The letter,…